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ABSTRACT 
 
A gel forming Polysaccharide gum obtained form the bark 
of Araucaria bidwilli was employed as a matrix sustained 
release tablet formulation of Diclofenac sodium (a non 
steroidal anti inflammatory agent). The effect of Araucaria 
bidwilli gum (Natural) and Synthetic polymer 
Hydroxypropyl methyl cellulose (HPMC K4 M) on the 
release of Diclofenac sodium was studied. The FT-IR 
spectroscopic studies of drug, gum and mixture indicated 
no chemical interaction. Six formulations were prepared by 
wet granulation method containing Araucaria bidwilli gum 
powder concentration 10% 20% & 30% w\w and 10% 20% 
&30% w\w of HPMC K4 M with sufficient volume of 
granulating agent Polyvinyl pyrrolene (PVP K 30), Avicel 
pH101 as diluents, Magnesium stearate and Aerosil is used 
lubricant and glidant respectively.This study was carried 
out to find out the difference between synthetic and natural 
gum and whether synthetic gum can be replaced by natural 
gums. Physical and technological studies of granules and 
tablets were compliance with Pharmacopoial standards.The 
drug release increased with Araucaria bidwilli  gum when 
compared to synthetics polymer concentration .The value 
of release exponent were found to be almost straight line 
and regression coefficient value between 0.938 and 
0.998.This implies that the release mechanism is diffusion. 
Formulation F3 ( contained 30% w\w Araucaria bidwilli 
gum) met the desired requirements for a sustained release 
dosage form.  
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INTRODUCTION:    
       
Apart from drugs and biologically active compounds, the 
plants also play an important role in pharmaceutical 
preparation like tablets,capsules,lotion,suspension,syrup 
and ointment etc1.The most common excipients of plant 
origin include acacia, tragacanth, sodium alginate, starch 
and cellulose,which have wide variety of application in 
pharmaceutical dosage form. Recent trend towards the use 
of the plant and nontoxic products demands the 
replacement of synthetic additives with natural one. 
Araucaria bidwilli  gum provide appropriate solution to the 
current problem. In view of the easy availability of the 
plant and the high demand on the gum through out the 
world, the gum obtained from Araucaria bidwilli  was 
investigated for its application as a release modifier. 
Araucaria bidwilli (Araucariaceae) is a large evergreen 
tree, native of Australia2-3. Various experimental reports 
indicared diclofenac sodium as a good candidate for 
sustained release SR formulation 4-5. The present study was 
undertaken to find out the potential of gum from Araucaria 
bidwilli to act as a release modifier in SR matrix tablet 
formulation. 
 
MATERIALS AND METHODS: 
 
Materials: 
Diclofenac sodium was obtained as a gift sample 
from Dr.Reddy,s Laboratories, Hyderabad,India. Araucaria 
bidwilli  bark gum was collected  from places in and around 
Ooty (Tamilnadu) .The plant was originally authenticated 
by Department of pharmacognosy. A  herbarium sample of 
this plant is preserved at the Department of 
pharmacognosy, JSS college of pharmacy Ooty. Hydroxy 
propyl methyl cellulose (HPMC K4-M), Polyvinyl 
pyrrolene (PVP K30) ,Microcrystalline cellulose (Avicel 
pH 101), Magnesium stearate and Aerosil were procured 
from SD Fine chemicals,Mumbai,India.  
 
Isolation of gum: 
The crude gums were soaked in a  distilled water over night 
until it was dissolved completely in water to form colloidal 
solution .This viscous solution obtained was passed through 
the muslin. The mucilage was precipitated out by addition 
of acetone. The  coagulated mass was dried in oven at 400C 
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for 2 hours, made into fine powder, passed though sieve 
number 100 and stored for further use in desiccators 6-7.     
Identification of gum: 
In freshly prepared coralline soda, the sample was mounted 
and covered with coverslip. After few seconds it was 
irrigated with 25% Sodium carbonate solution. The 
polysaccharide gum power was stained pink colour. 
Physicochemical properties of gum: 
The physicochemical properties such as solubility, loss on 
drying and total ash content were determined according to 
Indian pharmacopoeial  procedure 8  using air dried powder 
of gum. The pH of the gum was determined using digital 
pH meter 9. The viscosity of 1% gum solution was 
determined at 250C using Oswald’s viscometer after 24 
hours of hydration.  
 
Compatibility studies: 
FT-IR spectra matching approach was used for detection of 
any possible chemical interaction between the drug and 
gum. The individual and physical mixture (1:1) of drug and 
gum powder was prepared and mixed with suitable quantity 
of potassium bromide. About 50 mg of this mixture was 
compressed to form a transparent pellet using a hydraulic 
press at 15 tons pressure. It was scanned from 4000 - 400 
cm-1 in a Perkin Elmer FTIR spectrophotometer. The IR 
spectrum of the physical mixture was compared with those 
of pure drug and matching was done to detect any 
appearance or disappearance of peak.    
Placebo tablet formulation: 
Tablets were prepared  using Avicel pH101 (quantity 
varied with concentration of gum), 10 % PVP K-30 as a 
binder and 2% Magnesium stearate as lubricant. Araucaria 
bidwilli powder gum was used as a release modifier in the 
concentration range of 10-30 % for preparation of granules. 
Granulation: 
Wet granulation technique used for the preparation of 
granules. All the excipient passed through to 80 mesh. 
Required quantity of Diclofenac sodium, Avicel pH101 and 
Araucaria bidwilli powder gum (120#) were mixed 
thoroughly and add sufficient quantity of granulation agent 
(PVP K 30 in water was added slowly) to obtained a damp 
mass suitable for granulation. The dump mass was passed 
through 8 mesh and granules were allowed to dry at 40 0C 
for 3-4 hours  then shifted through 22 mesh.  
Preformulation studies of granules: 
Preformulation work is an important aspect of formulation 
,which is monitored by  requisite parameters, such as angle 
of repose, percentage compressibility, percentage drug 
content and percentage of fine etc. Performulation  work 
was carried out on granules prepared using Araucaria 
bidwilli gum the result obtained were compared with those 
of HPMC K4 M 10-11 . The sample were graded as 
excellent, good ,fair or meager if the angel of repose was 
found to be is the range of 30-32,32-35,35-37 or 37-45 
respectively by fixed funnel method. Carrs index 
(percentage compressibility ), percentage drug content were 
calculated using standard formulae 12-13. 
Tabletting: 
The granules were homogenised with 0.5%  Aerosil and 
lubricated with 2% Magnesium stearate .The tablet of 
average weights 200 mg were prepared on 10 stations  
rotary compression machine(Rimek,Ahamedabad ,India) 
using 8 mm diameter standard concave punch set. The 
batch size prepared was of 250 tablets. The compressed 
tablets were stored in a closed container for 15 days, no 
significant evidence of chemical change was observed. The 
tablets formulation using different concentration of 
Araucaria bidwilli gum and HPMC K4 M were given in 
Table 1. (For each one tablet) as F1,F2&F3 denoting 
natural gum and H1,H2,&H3 as synthetic gum. 
Tablets Evaluation: 
The compressed tablets were evaluated for physical 
parameters such as average weight, content uniformity, 
hardness, friability using standard formulae 14-15. Swelling 
index of the formulated sustained release matrix tablets of 
Araucaria bidwilli gum was determined. A single tablet 
(Initial weight W1) was placed in 6.8 pH buffer  in a petri 
dish and the different time intervals the tablets was 
withdrawn. Excess buffer on the surface of the tablets was 
blotted with filter paper and reweighed (W2).Swelling 
index was calculated using the formula 16-17.   
Swelling index (%)  = [(W1-W2)100]/W1 
In vitro drug releases studies of compressed tablet were 
carried out in USP XXIII tablet dissolution test apparatus-II 
(Electrolab) employing a paddle stirrer rotating at 50 rpm, 
900 ml pH 6.8 phosphate buffer was used as a dissolution 
medium. The temperature of the dissolution medium was 
maintained at 37 ±0.50C throughout the experiment18-
19.One tablet was used in each test,5 ml of sample of 
dissolution medium was withdrawn. The sample were 
filtered through 0.45 μm membrane filter at specified 
intervals of time for period of 8 hours and was immediately 
replaced with fresh medium. Te sample was analysed for 
drug release by measuring the absorbance at 274 nm using 
UV-visible spectrophotometer(Techcom 2310 model) after 
suitable dilution.The content of drug and cumulative 
percentage drug release was calculated using an equation 
obtained from standard curve. 
Kinetic modeling of drug release: 
The dissolution profile of all the batches was fitted to 
various models such as Zero order, First order 20Higuchi 
21and Korsmeyer peppas 22-23 to ascertain the kinetic 
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Accelerated Stability Studies: 
 Stability study was carried out to observe the effect of 
temperature and relative humidity on optimized 
formulation (F3), by keeping room temperature (28oC) and 
at 40 ± 20C , in airtight container for three month, at RH 
75±5 %. Physical evaluation and invitro drug release was 
carried out after every one month. 
 
 
RESULTS AND DISCUSSION: 
 
Many natural gums are found to possess high viscosity 
which can be useful as release modifier in the preparation 
of sustained release(SR) formulation. Where as high 
viscosity nature could be helpful in the formulation of gel 
layer around the matrix system through which it can act as 
release modifier. A pharmaceutical technologist should be 
very careful in optimizing the concentration of gum in the 
formulation based on the dosage form requirement. 
 
In our preliminary studies, we observed that the natural 
gum gave positive result with polysaccharides test.  Gum 
obtained from the Araucaria bidwilli bark was an 
amorphous free flowing powder with a light brown colour. 
It exhibited good solubility in water and gave viscous 
solution on standing. It has pH between 6-7 with acceptable 
limit  loss on drying (LOD) and total ash content as shown 
in Table 2. In this present work Fig 1,2 &3 shows the IR 
spectra of Diclofenac sodium, Araucaria bidwilli gum and 
physical mixture of Diclofenac sodium and Araucaria 
bidwilli gum were performed. All the characteristic 
absorption bands of the pure drug and Araucaria bidwilli 
gum in the spectra of the formulation, without any shift in 
their position. It clearly suggests that the drug and the gum 
Araucaria bidwilli  have not undergone any chemical 
change hence there was no interaction between Diclofenac 
and Araucaria bidwilli gum. The prepared granules are 
evaluated for angle of repose, percentage compressibility, 
percentage drug content and percentage of fine results are 
tabulated in Table 3 .The flow property of granules was 
determined by angle of repose and it was found that values 
were between 23-260C.It was found that natural gum and 
synthetic granules exhibited excellent flow properties, as 
there is no significant difference between  percentage drug 
content and percentage fine. 
 
The percentage compressibility (Carrs index) of Araucaria 
bidwilli gum granules comparatively less than that of 
HPMC K4 M granules. The values of carrs index between 
11-15 indicant that the granules prepared using natural gum 
exhibit excellent flow property. Then the granules were 
compressed to tablets. 
 
The evaluation of tablet formulation using natural gum and 
synthetic were based on quality control parameters which 
include average weight of the tablet (weight variation) 
hardness, percentage friability, uniformity content and 
swelling index. The results are indicated in Table 4, all the 
batches of tablets prepared fulfilled the official (IP) 
requirement for uniformity of weight. Hardness of the 
tablets in all the batches was found to be in the range of 5-
5.5.kg /m2 and was satisfactory. The percentage friability of 
tablets prepared using natural gum ranged between 0.4-0.7 
%, which is almost equal to that of synthetic polymer used. 
The percent weight loss in the friability test from all 
formulation was found to be with in pharmacopoeial limit. 
All the tablets prepared were found to contain the 
medicament with 100 ± 5% of labeled claim.  
 
Higher swelling index was found for tablets of F3 batch 
containing 30% of Araucaria bidwilli gum .Thus, the 
concentration of natural gum had major influence on 
swelling process and matrix integrity. Hence from the 
above result, it can be concluded the linear relationship 
between swelling process and concentration of natural gum 
ratio is as shown Figure 4.  
 
Figure 5 and Figure 6 The invitro dissolution profile of 
using natural gum and synthetic polymer tablets 
formulated. Dissolution study showed that the drug releases 
from the tablets containing 10 to 20 %w/w of natural gum 
and 10 to 20% w/w of synthetic polymer was more than 
50% release after 8 hours. The tablets  at 30% w/w gum 
shown more optimum result as release modifier. The drug 
releases from the tablets decreases with the increases in 
gum concentration.  
 
The result of dissolution data from dissolution profile fitted 
to various drug release kinetic equation of zero order, first 
order, Higuchi plot and Korsmeyer peppas having ‘R2’, ‘n’ 
and ‘k’. ‘R2’  is value of correlation coefficient ‘k’ is a 
release rate constant and ‘n’ is the diffusional release 
exponent. 
 
The different release mechanism as n= 0.5 (Fikian 
diffusion), 0.5 < n < 1 (Anomalous transport), n=1 (case II 
transport i.e. Zero order release) and n>1 (super case II 
transport). 
 
The correlation coefficient ‘R2’ values were calculated 
using the linear regression analysis to find out the best 
fitted model and in order to have an about the Kinetic 
mechanism of drug release. The Higuchi model and 
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Korsmeyer peppas model found to be best fitted in all six 
formulation (F1, F2, F3, H1, H2 & H3). 
 
The correlation coefficient values between 0.938  to 0.998  
followed by first order kinetic drug release equation and the 
value of ‘n’ was found to range from 0.300 to 0.605 shown 
in Table 5.Which indicate that the release mechanism 
shifted in the direction of anomalous transport (except 
H1&H2)  and diffusion mechanism with erosion. The result 
of invitro dissolution studies of formulation F3 (30%w/w of 
Araucaria bidwilli gum) was found to be ideal for the 
formulation of SR matrix tablets , at it provides desired 
sustaining effect. Stability studies(40 ± 20C /RH 75±5 
%)revealed that there was no significant change in 
hardness, friability, drug content and dissolution profile of 
selected batch for 6 months indicate that Araucaria bidwilli 
was stable in matrix SR table of Diclofenac sodium.  
 
 
Table 1: Composition Diclofenac sodium sustained release matrix tablets 
 
 
Ingredients (mg/tablets) F1 F2 F3 H1 H2 H3 
Diclofenac Sodium 100 100 100 100 100 100 
Araucaria bidwilli 20 40 60 - - - 
HPMC K4-M - - - 20 40 60 
Avicel pH 101 55 35 15 55 35 15 
PVP K-30 (20% W/W in water) 20 20 20 20 20 20 
Magnesium stearate 04 04 04 04 04 04 
Aerosil 01 01 01 01 01 01 




Table 2: Physicochemical properties of Araucaria bidwilli gum powder 
 
Parameters Values 
Solubility Freely soluble in water 
pH 6-7 
Loss on drying 8% w/w 
Total ash content 2.5 %w/w 
Viscosity (1% w/w) 53.40 cps 
 
 
Table 3: Preformulation studies of prepared granules (wet granulation) 
 
Parameters F1 F2 F3 H1 H2 H3 
Angle of repose 23.50 24.69 25.46 24.44 23.49 23.48 
Carss index 12 13.1 13.1 19.1 22.00 18.00 
% Drug content 98.65 99.87 98.54 97.85 96.32 99.64 
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Table 5: Kinetic values obtained from in vitro release profile for matrix tablets of Diclofenac sodium (Higuchi’s and Korsmeyer 























Figure 1: FT-IR   Spectrum of Diclofenac sodium 
 
 
Parameters F1 F2 F3 H1 H2 H3 
Average weight  199.45 202.00 204.23 196.88 201. 91 203. 09 
Hardness (Kg/m2) 05.10±1 05.20±1.5 05.50±1.4 05.40±1.1 05.50±1.2 05.50±1.1 
Friability (%) 0.50 0.57 0.47 0.46 0.78 0.34 
Content uniformity(%) 99.76±0.6 98.04±0.7 99.03±0.5 97.56±0.3 99.42±0.4 100.35±0.4 





‘ R2’ ‘n’ ‘ R2’ ‘n’ 
AB gum 
F1 0.997 0.559 0.998 0.576 
F2 0.994 0.549 0.997 0.552 
F3 0.992 0.598 0.990 0.584 
HPMC 
H1 0.941 0.361 0.938 0.345 
H2 0.985 0.300 0.994 0.426 
H3 0.984 0.605 0.969 0.593 
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CONCLUSION: 
The present study revealed that Araucaria bidwilli gum 
appears to be suitable for use as a release modifier in the 
manufacture of once daily sustained release matrix tablets 
because of its good swelling index, good flow and 
suitability for matrix formulations. It could be concluded 
that Araucaria bidwilli gum can be used as an effective 
matrix former in the release of diclofenac sodium for 
sustained period of time.  
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